This finding was not confirmed by the present study where anti-cN-1A reactivity was detectable in none of the patients with Sjögren’s syndrome and in not more than 6.1% of patients with systemic lupus erythematosus, although the relatively small patient numbers allow only limited conclusions. This evidence concerns the gene NT5C1A and Sjogren syndrome.